Navigation Links
Amgen Statement on European Investor Visit
Date:11/14/2011

our competitors.  We depend on third parties for a significant portion of our manufacturing capacity for the supply of certain of our current and future products and limits on supply may constrain sales of certain of our current products and product candidate development.  In addition, we compete with other companies with respect to some of our marketed products as well as for the discovery and development of new products.  Discovery or identification of new product candidates cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate will be successful and become a commercial product.  Further, some raw materials, medical devices and component parts for our products are supplied by sole third-party suppliers.  Our business performance could affect or limit the ability of our Board of Directors to declare a dividend or our ability to pay a dividend or repurchase our common stock.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)  

(Logo:  http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale. Target Rationale for S1P1 Agonists Explained.
2. Back-Up Compounds and S1P1 Lead Compounds, Assets Generated by Epix Pharmaceuticals, Inc. and Amgen, Will Be Offered for Sale at a December 8, 2011 Sealed Bid Sale
3. Amgen Announces Webcast of 2011 Third Quarter Financial Results
4. Amgen Highlights Data to be Presented at 2011 European Multidisciplinary Cancer Congress
5. Amgen to Present at the Bank of America Merrill Lynch Global Healthcare Conference
6. Amgen to Present at the Morgan Stanley Global Healthcare Conference
7. Amgen to Present at the Baird Healthcare Conference
8. Amgen to Present at the Stifel Nicolaus Healthcare Conference
9. Amgen Announces PDUFA Date for XGEVA® Supplemental Biologics License Application
10. Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
11. Amgen Announces Webcast of 2011 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aug. 1, 2014 Research and ... "Global Medical Biosensors Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Medical biosensors are used ... physicochemical detectors. These biosensors monitor health status, disease ... non-invasive methods. They are cost-effective and user-friendly devices. ...
(Date:8/1/2014)... PALO ALTO, Calif. , Aug. 1, 2014 ... today announced a partnership to expand awareness of proper ... the CFChef Shares program. CFChef Shares will run from ... AbbVie,s CFChef program – an online resource for CF ... a healthy diet by submitting recipes to the ...
(Date:8/1/2014)... -- According to the new research ... infective), Basic (Films, Cleansing), Advanced (Hydrogels, Hydrocolloids, Alginate, ... Relief Devices, NPWT) - Global Forecast to 2019" ... expected to reach $18.3 Billion by 2019 from ... of 3.2% from 2014 to 2019. ...
Breaking Medicine Technology:Global Medical Biosensors Market 2014-2018: Key Vendors are Abbott, Bayer, LifeScan and F. Hoffmann-La Roche 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 2AbbVie and Cystic Fibrosis Research, Inc. (CFRI) Team Up to Raise Awareness of the Nutritional Needs of CF Patients through the CFChef Shares Program 3Wound Care Market Worth $18.3 Billion by 2019 2Wound Care Market Worth $18.3 Billion by 2019 3
... Stiefel, a GSK company, today announced the launch of the ... the United States. The launch will occur in the technical ... New Orleans. Indicated for the treatment of acne, Stiefel will ...   PanOxyl ® Acne Creamy Wash will be available in ...
... MEDfx Corporation today announced a Direct Project pilot that ... of the standards and protocols supported by the Direct ... in, and is a contributor to, the nationally-sponsored Direct ... Health IT.  The MEDfx Direct pilot will be demonstrated ...
Cached Medicine Technology:Stiefel Launches Most-Prescribed BPO Wash Formulations Over-the-Counter 2MEDfx to Harmonize the Direct Project With CONNECT 2MEDfx to Harmonize the Direct Project With CONNECT 3
(Date:8/1/2014)... (HealthDay News) -- Roaming the high Alps more than ... as the "Ice Man" no doubt had a very tough ... not have shielded the Ice Man, nicknamed Otzi, from a ... for atherosclerosis, or "hardening of the arteries," appears to be ... a new study finds. "Our ancestors going back ...
(Date:8/1/2014)... , Parkinson,s disease affects ... activity ceases and the cells die. Researchers at the Max ... supplying D-lactate or glycolate, two products of the gene DJ-1, ... to cultured HeLa cells and to cells of the nematode ... prevented the degeneration of neurons. They also showed that the ...
(Date:8/1/2014)... 01, 2014 The North America Sports Drink ... North America, with analysis and forecast of revenue. The Sports ... around $5,021.9 million in 2012 to $6,243 million by 2018, ... Browse through the TOC of the North America Sports Drink ... provided. This also provides a glimpse of the segmentation in ...
(Date:8/1/2014)... Gerontological Society of America (GSA) ... field of aging has chosen Madonna Harrington ... PhD, of the University of Luxembourg; and Philipp ... The London School of Economics and Political Science ... Innovative Publication Awards. , These distinguished honors recognize ...
(Date:8/1/2014)... According to Forrester Research, more than 90 ... in search of information, and thanks to the launching of ... information and resources on insurance specifically for the state of ... this next step in the growth of our business,” Doug ... - Commercial Insurance Resources office. “We recognize that the web ...
Breaking Medicine News(10 mins):Health News:'Ice Man' Mummy May Have Been at Risk of Heart Disease 2Health News:Potential treatment and prevention of Parkinson's disease 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 2Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 3Health News:North America Sports Drinks Market is Expected to Reach $6,243 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Harrington Meyer, Leist, Hessel, Avendano to receive GSA's 2014 Kalish awards 2Health News:DCInsurers Agent Doug King Launches a New Website 2Health News:DCInsurers Agent Doug King Launches a New Website 3
... HealthDay Reporter , TUESDAY, Sept. 13 (HealthDay News) -- ... aortic valve live in fear of sudden death, but a ... complication called aortic dissection. However, these people are at ... or bulge in the wall of the aorta, researchers report. ...
... children with autism spectrum disorder (ASD), routine medical procedures ... difficult. Communication and social interaction deficits and reliance on ... the significant factors to be considered when preparing a ... effort to help families and medical providers make necessary ...
... of Boston,s elderly homeless population is emerging from a ... Hebrew SeniorLife, an affiliate of Harvard Medical School. The ... rates of geriatric syndromes, including functional decline, falls, frailty ... that many of these conditions may be easily treated ...
... a widely prescribed class of drugs used to lower cholesterol, ... in people who,ve had strokes, new research finds. Statins ... caused by blocked blood flow to the brain, to reduce ... raised concerns that statins might also raise the risk of ...
... Health and Sanford-Burnham Medical Research Institute (Sanford-Burnham) have ... laboratory scientists uncovering new approaches for treating cancer ... Basic medical research often struggles to achieve ... into medical practice. The field of translational medicine ...
... that taking the anti-inflammatory drug celecoxib can reduce the ... at the cost of increasing the risk of heart ... Researchers at Winship Cancer Institute of Emory University ... cells into suicide, separately from its known effects. The ...
Cached Medicine News:Health News:Heart Defect Seems to Pose Low Risk of Aorta Tear 2Health News:Autism Speaks launches 'blood draw' tool kit -- practical guidance for parents and providers 2Health News:Autism Speaks launches 'blood draw' tool kit -- practical guidance for parents and providers 3Health News:Institute for Aging Research study finds Boston's elderly homeless sicker than others 2Health News:Statins Don't Raise Risk of Brain Bleeds After Stroke: Study 2Health News:Scripps Health and Sanford-Burnham to collaborate to advance new cancer treatments 2Health News:Separating a cancer prevention drug from heart disease risk 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: